Maintaining stability of sinus rhythm in atrial fibrillation: Antiarrhythmic drugs versus ablation

Keyphrases

• Ablation 100%
• Atrial Fibrillation 100%
• Sinus Rhythm 100%
• Antiarrhythmic Drugs 100%
• Rate Control 66%
• Amiodarone 33%
• Arrhythmia 33%
• Drug Choice 33%
• Pulmonary Vein 33%
• Catheter 33%
• Beta-blockers 33%
• Quinidine 33%
• Effects on Survival 33%
• Congestive Heart Failure 33%
• Verapamil 33%
• Pharmacological Therapy 33%
• Therapeutic Strategies 33%
• Left Atrium 33%
• Non-pharmacological Methods 33%
• Catheter Ablation 33%
• Diltiazem 33%
• Propafenone 33%
• Dofetilide 33%
• Flecainide 33%
• Sotalol 33%
• Defibrillator 33%
• Digoxin 33%
• Structural Heart Disease 33%
• Non-pharmacological 33%
• Drug Refractory 33%
• Procainamide 33%
• Refractory Patients 33%
• Left Atrial Function 33%
• Post-myocardial Infarction Heart Failure 33%
• Neutral Effects 33%
• High Recurrence Rate 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Antiarrhythmic Agent 100%
• Amiodarone 25%
• Heart Arrhythmia 25%
• Quinidine 25%
• Recurrent Disease 25%
• Heart Infarction 25%
• Congestive Heart Failure 25%
• Verapamil 25%
• Recurrence Risk 25%
• Heart Disease 25%
• Diltiazem 25%
• Sotalol 25%
• Dofetilide 25%
• Flecainide 25%
• Propafenone 25%
• Thromboembolism 25%
• Digoxin 25%
• Disopyramide 25%
• Procainamide 25%